Alimera Sciences, Inc.
ALIM · NASDAQ
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
|---|---|---|---|---|
| Market Cap | $300,200 | $209,274 | $235,107 | $99,529 |
| - Cash | $10,861 | $14,346 | $12,090 | $8,285 |
| + Debt | $72,157 | $72,255 | $67,399 | $64,415 |
| Enterprise Value | $361,496 | $267,183 | $290,416 | $155,659 |
| Revenue | $27,000 | $23,011 | $26,306 | $23,364 |
| % Growth | 17.3% | -12.5% | 12.6% | – |
| Gross Profit | $23,169 | $16,573 | $22,680 | $17,446 |
| % Margin | 85.8% | 72% | 86.2% | 74.7% |
| EBITDA | $2,892 | $541 | $4,020 | $3,929 |
| % Margin | 10.7% | 2.4% | 15.3% | 16.8% |
| Net Income | -$3,311 | -$6,251 | -$3,781 | -$1,354 |
| % Margin | -12.3% | -27.2% | -14.4% | -5.8% |
| EPS Diluted | -0.061 | -0.11 | -0.07 | -0.042 |
| % Growth | 44.6% | -58.3% | -64.7% | – |
| Operating Cash Flow | $1,026 | -$566 | $3,770 | -$9,826 |
| Capital Expenditures | -$111 | -$21 | -$85 | -$4 |
| Free Cash Flow | $915 | -$587 | $3,685 | -$9,830 |